Effects of GIP receptor-modulating compounds on different tissues have implications for both weight reduction and other cardiometabolic diseases. Further study is needed to understand the implications of GIP agonism on not just weight reduction, but also cardiovascular disease, liver disease, bone health and fat storage.
Keyphrases
- weight loss
- cardiovascular disease
- weight gain
- body mass index
- physical activity
- type diabetes
- healthcare
- metabolic syndrome
- public health
- insulin resistance
- adipose tissue
- gene expression
- mental health
- bone mineral density
- randomized controlled trial
- body weight
- fatty acid
- risk assessment
- soft tissue
- phase ii
- coronary artery disease
- high fat diet induced
- open label
- cardiovascular risk factors